168 results
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
Independent
Directors
Dr. Francesco Bellini
Roberto Bellini
Dr. Youssef L. Bennani
Franklin M. Berger
Dr. Clarissa Desjardins (1)
Pierre Larochelle
Dr … ) Limited (“Mercer”) as its independent compensation consultant to advise on executive and Board compensation matters including: overall compensation
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
independent legal advice, as the failure to comply strictly with the provisions of the Canada Business Corporations Act, as modified by the Interim … continues as an independent Entity, there are risks that the announcement of the Arrangement and the dedication of substantial resources by the Company
6-K
EX-99.2
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
, or individual who is a current or former independent contractor, consultant, or director, of or to the Company or any Company Subsidiary.
“Company … 1.368-2(g). None of the Parties knows of any fact or circumstance (without conducting independent inquiry or diligence of the other relevant Parties
6-K
EX-99.3
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
the opportunity to obtain independent legal advice and confirms by the execution of this letter agreement that he or she has either done so or waived his … or her right to do so in connection with the entering into of this letter agreement, and that any failure on the undersigned’s part to seek independent
6-K
EX-99.2
BLU
Bellus Health Inc
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
and Corporate Governance Committee
Independent Directors
Dr. Francesco Bellini
Roberto Bellini
Dr. Youssef L. Bennani
Franklin M. Berger
Dr. Clarissa … Mercer (Canada) Limited (“Mercer”) as its independent compensation consultant to advise on executive and Board compensation matters including: overall
6-K
EX-99.1
8whwb7lxwp8x
29 Mar 23
Current report (foreign)
5:26pm
6-K
EX-99.2
0u96t33q31i xg1k
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
SUPPL
9sgs4h4imryyx2d1 2xj
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
juhxi4
14 Nov 22
Open Market Sale Agreementsm
5:19pm
F-10
EX-5.1
kgbkmrve8g5qa8
26 Aug 22
Registration of securities (Canada)
4:48pm
F-10
zhas8yi 2q
26 Aug 22
Registration of securities (Canada)
4:48pm
6-K
EX-99.2
b1tipokgt5l6gfa
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
SUPPL
t0diegh864pd l2
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
EX-99.2
3vg1afasix4
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
SUPPL
didnyc r4w3kcaf
13 Jul 22
Supplemental materials (foreign)
5:01pm
6-K
EX-99.2
sy8joaxx12 55f3ra
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
S-8
EX-23.2
824nzxkogsjmlrld
19 Apr 22
Registration of securities for employees
4:14pm
6-K
EX-99.2
nfg21yle
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
6-K
EX-99.1
e6uxy37 5isge46gh
5 Apr 22
Current report (foreign)
4:07pm
40-F
740re0u0ago lw5hrv8r
23 Feb 22
Annual report (Canada)
5:20pm